BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 38263029)

  • 1. Electronic aggregated data collection on cervical cancer screening in Bangladesh since 2014: what the data tells us?
    Nessa A; Hossain MS; Uddin SMN; Islam MR; Khan MAH; Azad AK
    BMC Public Health; 2024 Jan; 24(1):270. PubMed ID: 38263029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of print and audiovisual media in cervical cancer prevention in Bangladesh.
    Nessa A; Hussain MA; Rashid MH; Akhter N; Roy JS; Afroz R
    Asian Pac J Cancer Prev; 2013; 14(5):3131-7. PubMed ID: 23803091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leveraging vertical COVID-19 investments to improve monitoring of cancer screening programme - A case study from Bangladesh.
    Basu P; Lucas E; Zhang L; Muwonge R; Murillo R; Nessa A
    Prev Med; 2021 Oct; 151():106624. PubMed ID: 34023359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the National Cervical Cancer Screening Programme of Bangladesh and the formulation of quality assurance guidelines.
    Basu P; Nessa A; Majid M; Rahman JN; Ahmed T
    J Fam Plann Reprod Health Care; 2010 Jul; 36(3):131-4. PubMed ID: 20659365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perceptions and experiences with district health information system software to collect and utilize health data in Bangladesh: a qualitative exploratory study.
    Begum T; Khan SM; Adamou B; Ferdous J; Parvez MM; Islam MS; Kumkum FA; Rahman A; Anwar I
    BMC Health Serv Res; 2020 May; 20(1):465. PubMed ID: 32456706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison between visual inspection of cervix and cytology based screening procedures in Bangladesh.
    Nessa A; Nahar KN; Begum SA; Anwary SA; Hossain F; Nahar K
    Asian Pac J Cancer Prev; 2013; 14(12):7607-11. PubMed ID: 24460341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening for cervical neoplasia in Bangladesh using visual inspection with acetic acid.
    Nessa A; Hussain MA; Rahman JN; Rashid MH; Muwonge R; Sankaranarayanan R
    Int J Gynaecol Obstet; 2010 Nov; 111(2):115-8. PubMed ID: 20674919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a visual inspection programme for cervical cancer prevention in Bangladesh.
    Ahmed T; Ashrafunnessa ; Rahman J
    Reprod Health Matters; 2008 Nov; 16(32):78-85. PubMed ID: 19027625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrated cervical cancer screening in Mayuge District Uganda (ASPIRE Mayuge): a pragmatic sequential cluster randomized trial protocol.
    Nakisige C; Trawin J; Mitchell-Foster S; Payne BA; Rawat A; Mithani N; Amuge C; Pedersen H; Orem J; Smith L; Ogilvie G
    BMC Public Health; 2020 Jan; 20(1):142. PubMed ID: 32005202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors affecting cervical cancer screening uptake, visual inspection with acetic acid positivity and its predictors among women attending cervical cancer screening service in Addis Ababa, Ethiopia.
    Fentie AM; Tadesse TB; Gebretekle GB
    BMC Womens Health; 2020 Jul; 20(1):147. PubMed ID: 32677933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cervical cancer screening programmes and age-specific coverage estimates for 202 countries and territories worldwide: a review and synthetic analysis.
    Bruni L; Serrano B; Roura E; Alemany L; Cowan M; Herrero R; Poljak M; Murillo R; Broutet N; Riley LM; de Sanjose S
    Lancet Glob Health; 2022 Aug; 10(8):e1115-e1127. PubMed ID: 35839811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Camp based awareness and screening programme of cervical cancer in rural area of Bangladesh.
    Shahida SM; Saha K; Banu KA; Islam MA
    Mymensingh Med J; 2013 Oct; 22(4):640-5. PubMed ID: 24292289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Community cancer screening at primary care level in Northern India: determinants and policy implications for cancer prevention.
    Sharma P; Khanna D; Pradhan S; Birur P
    Fam Med Community Health; 2023 Dec; 11(Suppl 1):. PubMed ID: 38105243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HPV testing compared with routine cytology in cervical screening: long-term follow-up of ARTISTIC RCT.
    Gilham C; Sargent A; Kitchener HC; Peto J
    Health Technol Assess; 2019 Jun; 23(28):1-44. PubMed ID: 31219027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of Cervical Intraepithelial Neoplasia in four Upazila of Dhaka Division.
    Shahida SM; Lipi LB; Rifat JA; Kutubi A; Haq K; Afroz R; Nessa A
    Mymensingh Med J; 2019 Jul; 28(3):655-661. PubMed ID: 31391440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer screening research in Bangladesh: Insights from a scoping review.
    Chowdhury MZI; Mubin N; Mohib T; Chowdhury N; Chowdhury TF; Laskar AMH; Sultana S; Raihan M; Turin TC
    Glob Public Health; 2024 Jan; 19(1):2351186. PubMed ID: 38752425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Women's Knowledge, Attitude and Practice on Cervical Cancer and Its Screening in Dhaka, Bangladesh.
    Qayum MO; Billah MM; Akhter R; Flora MS
    Asian Pac J Cancer Prev; 2021 Oct; 22(10):3327-3335. PubMed ID: 34711010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Introduction of primary screening using high-risk HPV DNA detection in the Dutch cervical cancer screening programme: a population-based cohort study.
    Aitken CA; van Agt HME; Siebers AG; van Kemenade FJ; Niesters HGM; Melchers WJG; Vedder JEM; Schuurman R; van den Brule AJC; van der Linden HC; Hinrichs JWJ; Molijn A; Hoogduin KJ; van Hemel BM; de Kok IMCM
    BMC Med; 2019 Dec; 17(1):228. PubMed ID: 31829241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Community-based HPV self-collection versus visual inspection with acetic acid in Uganda: a cost-effectiveness analysis of the ASPIRE trial.
    Mezei AK; Pedersen HN; Sy S; Regan C; Mitchell-Foster SM; Byamugisha J; Sekikubo M; Armstrong H; Rawat A; Singer J; Ogilvie GS; Kim JJ; Campos NG
    BMJ Open; 2018 Jun; 8(6):e020484. PubMed ID: 29895648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.